Global Epidermolysis Bullosa Therapeutics Market Professional Survey Report 2019

Table of Contents

Executive Summary

1 Industry Overview of Epidermolysis Bullosa Therapeutics

• 1.1 Definition of Epidermolysis Bullosa Therapeutics
• 1.2 Epidermolysis Bullosa Therapeutics Segment by Type
  • 1.2.1 Global Epidermolysis Bullosa Therapeutics Production Growth Rate Comparison by Types (2014-2025)
  • 1.2.2 EB-201
  • 1.2.3 FCX-007
  • 1.2.4 ICX-RHY
  • 1.2.5 INM-750
  • 1.2.6 Others
• 1.3 Epidermolysis Bullosa Therapeutics Segment by Applications
  • 1.3.1 Global Epidermolysis Bullosa Therapeutics Consumption Comparison by Applications (2014-2025)
  • 1.3.2 Clinic
  • 1.3.3 Hospital
  • 1.3.4 Others
• 1.4 Global Epidermolysis Bullosa Therapeutics Overall Market
  • 1.4.1 Global Epidermolysis Bullosa Therapeutics Revenue (2014-2025)
  • 1.4.2 Global Epidermolysis Bullosa Therapeutics Production (2014-2025)
  • 1.4.3 North America Epidermolysis Bullosa Therapeutics Status and Prospect (2014-2025)
  • 1.4.4 Europe Epidermolysis Bullosa Therapeutics Status and Prospect (2014-2025)
  • 1.4.5 China Epidermolysis Bullosa Therapeutics Status and Prospect (2014-2025)
  • 1.4.6 Japan Epidermolysis Bullosa Therapeutics Status and Prospect (2014-2025)
  • 1.4.7 Southeast Asia Epidermolysis Bullosa Therapeutics Status and Prospect (2014-2025)
  • 1.4.8 India Epidermolysis Bullosa Therapeutics Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis

• 2.1 Raw Material and Suppliers
• 2.2 Manufacturing Cost Structure Analysis of Epidermolysis Bullosa Therapeutics
• 2.3 Manufacturing Process Analysis of Epidermolysis Bullosa Therapeutics
• 2.4 Industry Chain Structure of Epidermolysis Bullosa Therapeutics

3 Development and Manufacturing Plants Analysis of Epidermolysis Bullosa Therapeutics

• 3.1 Capacity and Commercial Production Date
• 3.2 Global Epidermolysis Bullosa Therapeutics Manufacturing Plants Distribution
• 3.3 Major Manufacturers Technology Source and Market Position of Epidermolysis Bullosa Therapeutics
• 3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers

• 4.1 Epidermolysis Bullosa Therapeutics Production and Capacity Analysis
• 4.2 Epidermolysis Bullosa Therapeutics Revenue Analysis
• 4.3 Epidermolysis Bullosa Therapeutics Price Analysis
• 4.4 Market Concentration Degree

5 Epidermolysis Bullosa Therapeutics Regional Market Analysis

• 5.1 Epidermolysis Bullosa Therapeutics Production by Regions
  • 5.1.1 Global Epidermolysis Bullosa Therapeutics Production by Regions
  • 5.1.2 Global Epidermolysis Bullosa Therapeutics Revenue by Regions
• 5.2 Epidermolysis Bullosa Therapeutics Consumption by Regions
• 5.3 North America Epidermolysis Bullosa Therapeutics Market Analysis
  • 5.3.1 North America Epidermolysis Bullosa Therapeutics Production
  • 5.3.2 North America Epidermolysis Bullosa Therapeutics Revenue
  • 5.3.3 Key Manufacturers in North America
  • 5.3.4 North America Epidermolysis Bullosa Therapeutics Import and Export
• 5.4 Europe Epidermolysis Bullosa Therapeutics Market Analysis
  • 5.4.1 Europe Epidermolysis Bullosa Therapeutics Production
  • 5.4.2 Europe Epidermolysis Bullosa Therapeutics Revenue
  • 5.4.3 Key Manufacturers in Europe
  • 5.4.4 Europe Epidermolysis Bullosa Therapeutics Import and Export
• 5.5 China Epidermolysis Bullosa Therapeutics Market Analysis
  • 5.5.1 China Epidermolysis Bullosa Therapeutics Production
  • 5.5.2 China Epidermolysis Bullosa Therapeutics Revenue
  • 5.5.3 Key Manufacturers in China
  • 5.5.4 China Epidermolysis Bullosa Therapeutics Import and Export
• 5.6 Japan Epidermolysis Bullosa Therapeutics Market Analysis
  • 5.6.1 Japan Epidermolysis Bullosa Therapeutics Production
  • 5.6.2 Japan Epidermolysis Bullosa Therapeutics Revenue
  • 5.6.3 Key Manufacturers in Japan
  • 5.6.4 Japan Epidermolysis Bullosa Therapeutics Import and Export
• 5.7 Southeast Asia Epidermolysis Bullosa Therapeutics Market Analysis
  • 5.7.1 Southeast Asia Epidermolysis Bullosa Therapeutics Production
  • 5.7.2 Southeast Asia Epidermolysis Bullosa Therapeutics Revenue
  • 5.7.3 Key Manufacturers in Southeast Asia
  • 5.7.4 Southeast Asia Epidermolysis Bullosa Therapeutics Import and Export
• 5.8 India Epidermolysis Bullosa Therapeutics Market Analysis
  • 5.8.1 India Epidermolysis Bullosa Therapeutics Production
  • 5.8.2 India Epidermolysis Bullosa Therapeutics Revenue
  • 5.8.3 Key Manufacturers in India
  • 5.8.4 India Epidermolysis Bullosa Therapeutics Import and Export

6 Epidermolysis Bullosa Therapeutics Segment Market Analysis (by Type)

• 6.1 Global Epidermolysis Bullosa Therapeutics Production by Type
• 6.2 Global Epidermolysis Bullosa Therapeutics Revenue by Type
• 6.3 Epidermolysis Bullosa Therapeutics Price by Type

7 Epidermolysis Bullosa Therapeutics Segment Market Analysis (by Application)

• 7.1 Global Epidermolysis Bullosa Therapeutics Consumption by Application
• 7.2 Global Epidermolysis Bullosa Therapeutics Consumption Market Share by Application (2014-2019)

8 Epidermolysis Bullosa Therapeutics Major Manufacturers Analysis

• 8.1 Birken AG
  • 8.1.1 Birken AG Epidermolysis Bullosa Therapeutics Production Sites and Area Served
  • 8.1.2 Birken AG Product Introduction, Application and Specification
  • 8.1.3 Birken AG Epidermolysis Bullosa Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.1.4 Main Business and Markets Served
• 8.2 Fibrocell Science, Inc.
  • 8.2.1 Fibrocell Science, Inc. Epidermolysis Bullosa Therapeutics Production Sites and Area Served
  • 8.2.2 Fibrocell Science, Inc. Product Introduction, Application and Specification
  • 8.2.3 Fibrocell Science, Inc. Epidermolysis Bullosa Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.2.4 Main Business and Markets Served
• 8.3 GlaxoSmithKline Plc
  • 8.3.1 GlaxoSmithKline Plc Epidermolysis Bullosa Therapeutics Production Sites and Area Served
  • 8.3.2 GlaxoSmithKline Plc Product Introduction, Application and Specification
  • 8.3.3 GlaxoSmithKline Plc Epidermolysis Bullosa Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.3.4 Main Business and Markets Served
• 8.4 InMed Pharmaceuticals Inc.
  • 8.4.1 InMed Pharmaceuticals Inc. Epidermolysis Bullosa Therapeutics Production Sites and Area Served
  • 8.4.2 InMed Pharmaceuticals Inc. Product Introduction, Application and Specification
  • 8.4.3 InMed Pharmaceuticals Inc. Epidermolysis Bullosa Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.4.4 Main Business and Markets Served
• 8.5 Karus Therapeutics Limited
  • 8.5.1 Karus Therapeutics Limited Epidermolysis Bullosa Therapeutics Production Sites and Area Served
  • 8.5.2 Karus Therapeutics Limited Product Introduction, Application and Specification
  • 8.5.3 Karus Therapeutics Limited Epidermolysis Bullosa Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.5.4 Main Business and Markets Served
• 8.6 ProQR Therapeutics N.V.
  • 8.6.1 ProQR Therapeutics N.V. Epidermolysis Bullosa Therapeutics Production Sites and Area Served
  • 8.6.2 ProQR Therapeutics N.V. Product Introduction, Application and Specification
  • 8.6.3 ProQR Therapeutics N.V. Epidermolysis Bullosa Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.6.4 Main Business and Markets Served
• 8.7 RegeneRx Biopharmaceuticals, Inc.
  • 8.7.1 RegeneRx Biopharmaceuticals, Inc. Epidermolysis Bullosa Therapeutics Production Sites and Area Served
  • 8.7.2 RegeneRx Biopharmaceuticals, Inc. Product Introduction, Application and Specification
  • 8.7.3 RegeneRx Biopharmaceuticals, Inc. Epidermolysis Bullosa Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.7.4 Main Business and Markets Served
• 8.8 Scioderm, Inc.
  • 8.8.1 Scioderm, Inc. Epidermolysis Bullosa Therapeutics Production Sites and Area Served
  • 8.8.2 Scioderm, Inc. Product Introduction, Application and Specification
  • 8.8.3 Scioderm, Inc. Epidermolysis Bullosa Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.8.4 Main Business and Markets Served
• 8.9 Stratatech Corporation
  • 8.9.1 Stratatech Corporation Epidermolysis Bullosa Therapeutics Production Sites and Area Served
  • 8.9.2 Stratatech Corporation Product Introduction, Application and Specification
  • 8.9.3 Stratatech Corporation Epidermolysis Bullosa Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.9.4 Main Business and Markets Served
• 8.10 TWi Pharmaceuticals, Inc.
  • 8.10.1 TWi Pharmaceuticals, Inc. Epidermolysis Bullosa Therapeutics Production Sites and Area Served
  • 8.10.2 TWi Pharmaceuticals, Inc. Product Introduction, Application and Specification
  • 8.10.3 TWi Pharmaceuticals, Inc. Epidermolysis Bullosa Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.10.4 Main Business and Markets Served
• 8.11 WAVE Life Sciences Ltd.

9 Development Trend of Analysis of Epidermolysis Bullosa Therapeutics Market

• 9.1 Global Epidermolysis Bullosa Therapeutics Market Trend Analysis
  • 9.1.1 Global Epidermolysis Bullosa Therapeutics Market Size (Volume and Value) Forecast 2019-2025
• 9.2 Epidermolysis Bullosa Therapeutics Regional Market Trend
  • 9.2.1 North America Epidermolysis Bullosa Therapeutics Forecast 2019-2025
  • 9.2.2 Europe Epidermolysis Bullosa Therapeutics Forecast 2019-2025
  • 9.2.3 China Epidermolysis Bullosa Therapeutics Forecast 2019-2025
  • 9.2.4 Japan Epidermolysis Bullosa Therapeutics Forecast 2019-2025
  • 9.2.5 Southeast Asia Epidermolysis Bullosa Therapeutics Forecast 2019-2025
  • 9.2.6 India Epidermolysis Bullosa Therapeutics Forecast 2019-2025
• 9.3 Epidermolysis Bullosa Therapeutics Market Trend (Product Type)
• 9.4 Epidermolysis Bullosa Therapeutics Market Trend (Application)
• 10.1 Marketing Channel
  • 10.1.1 Direct Marketing
  • 10.1.2 Indirect Marketing
• 10.3 Epidermolysis Bullosa Therapeutics Customers

11 Market Dynamics

• 11.1 Market Trends
• 11.2 Opportunities
• 11.3 Market Drivers
• 11.4 Challenges
• 11.5 Influence Factors

12 Conclusion

13 Appendix

• 13.1 Methodology/Research Approach
  • 13.1.1 Research Programs/Design
  • 13.1.2 Market Size Estimation
  • 13.1.3 Market Breakdown and Data Triangulation
• 13.2 Data Source
  • 13.2.1 Secondary Sources
  • 13.2.2 Primary Sources
• 13.3 Author List